Skip to main content

Punch Biopsy Wounds

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Kerecis
KerecisIceland - Isafjordur
1 program
Punch biopsies treated with MariGen Wound ECM dressingN/A1 trial
Active Trials
NCT01917591Completed81Est. Jul 2013

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
KerecisPunch biopsies treated with MariGen Wound ECM dressing

Clinical Trials (1)

Total enrollment: 81 patients across 1 trials

NCT01917591KerecisPunch biopsies treated with MariGen Wound ECM dressing

Healing of Punch Graft Wounds. Comparative Study Between MariGen and Oasis: a Non-inferiority Study

Start: Jan 2013Est. completion: Jul 201381 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.